Long-Term Safety and Effectiveness of mRNA-1273 Vaccine in Adults: COVE Trial Open-Label and Booster Phases

Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases

Primary vaccination with mRNA-1273 (100-µg) was safe and efficacious at preventing coronavirus disease 2019 (COVID-19) in the previously reported, blinded Part A of the phase 3 Coronavirus Efficacy (COVE; NCT04470427) trial in adults (≥18 years) across 99 U.S. sites. The open-label (Parts B and C) primary objectives were evaluation of long-term safety and effectiveness of primary vaccination plus a 50-µg booster dose; immunogenicity was a second…

US Researchers Develop New mRNA Vaccine To Fight Covid-19

A team of US researchers has developed a new type of mRNA vaccine that is more scalable and adaptable to tackle continuously evolving viruses such as SARS-CoV-2 and H5N1.

New mRNA vaccine is more effective and less costly to develop, study finds

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a study by researchers at the University of Pittsburgh School of Public Health and the Pennsylvania State University. The study was published today in npj Vaccines.

Trans-Amplifying mRNA Vaccine Effective, Cheap to Develop

A new type of mRNA vaccine has been developed by researchers at the University of Pittsburgh and Pennsylvania State University that is more effective and cheaper to develop than vaccines currently on the market. The vaccine is still at an early stage and is yet to be tested in humans, but the researchers believe their prototype vaccine could help drug developers and health authorities respond more quickly to new pathogens or to new variants of k…

US researchers develop new mRNA vaccine to fight Covid-19

New Delhi, June 3 (IANS) Amid fresh surge in Covid-19 cases, a team of US researchers has developed a new type of mRNA vaccine that is more scalable and adaptable to tackle continuously evolving viruses such as SARS-CoV-2 and H5N1. While the currently available mRNA vaccines are highly effective at inducing an immune response against […]

Pitt Study Reveals New mRNA Vaccine Is More Effective and Cost-Efficient to

A groundbreaking new approach to mRNA vaccine technology promises to transform how scientists respond to rapidly mutating viruses, according to a recent study from the University of Pittsburgh School of Public Health and Pennsylvania State University. This innovative “trans-amplifying” mRNA platform stands to revolutionize vaccine development by dramatically reducing costs while enhancing efficacy against diverse viral variants, as detailed in t…